Alinta Energy to build 214MW wind farm at Yandin in Western Australia
By Nikita Chaurasia  Date: 2019-02-25

Alinta Energy to build 214MW wind farm at Yandin in Western Australia

Wind turbine manufacturer Vestas has been chosen to be Alinta’s engineering, procurement and construction partner for the project.

Alinta Energy has recently made an announcement confirming that it will go ahead with the construction of the 214 MW Yandin wind farm, north of Perth. Reportedly, the project would lead to building Western Australia’s biggest wind farm to date, beating the state’s 207 MW Collgar wind facility.

Initially proposed by the development firm Wind Prospect, the Yandin wind farm was apparently in the works for many years now. Alinta has finally appointed the leading wind turbine manufacturer Vestas as its engineering, procurement and construction partner for the project.

According to Alinta Energy, the Yandin wind farm would consist of 51 turbines from Vestas, having 4.2 MW capacity each, and would be delivering a capacity factor of nearly 50%. The company has received planning approval for installing 90 turbines, it said, but so far has decided to only use the best sites. The wind resource to be utilized by the wind farm for energy generation is considered to be fairly reliable and predictable.

Located about 175 kms north of Perth in the town of Dandaragan, the project is anticipated to cost nearly $400 million and would be creating close to 150 jobs during the construction phase. The company indicated that it could also add solar to the project at a later date, joining other projects where solar and wind are co-located.

Records confirm that in the previous year, Alinta Energy had called for up to 1,000 MW of solar and wind energy project tenders, for which it had received over 100 different proposals. Three of these proposals, targeted mainly at the NSW market, have apparently been selected by the company and the announcement regarding the first project could be made over the coming months.

Alinta mentioned that the Yandin wind farm is a separate deal, since it will be satisfying its own energy requirements and would be used to grow its industrial and commercial portfolio. The firm claims it would be able to deliver a considerable reduction in overall electricity costs.

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Fragomen acquires SimpleCitizen to reinforce its immigration services
Fragomen acquires SimpleCitizen to reinforce its immigration services
By Nikita Chaurasia

In a recent turn of events, Fragomen, Del Rey, Bernsen & Loewy, LLP, a leading corporate immigration law company has reportedly joined hands with SimpleCitizen Inc. to form Fragomen Technologies Inc., a new subsidiary which will provide a combina...

Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
By Nikita Chaurasia

Solar project development and asset management major, Nautilus Solar Energy LLC, has reportedly announced its acquisition of two solar portfolios in Rhode Island and Oregon amounting to a total of nearly 17 MW from leading solar energy developer, Pin...

Locate Bio obtains multiple late stage orthobiologics assets from RCSI
Locate Bio obtains multiple late stage orthobiologics assets from RCSI
By Nikita Chaurasia

Regenerative medicine major, Locate Bio, has reportedly announced its in-licensing of several late stage orthobiologics assets from the RCSI University of Medicine and Health Sciences. Sources state that the technologies created by the RCSI Tissue E...

Roche acquires Inflazome to gain control over inflammatory treatments
Roche acquires Inflazome to gain control over inflammatory treatments
By Nikita Chaurasia

In a recent turn of events, Swiss healthcare giant, F. Hoffmann-La Roche AG has reportedly acquired an Irish biotech firm Inflazome Ltd. for approximately USD 451 million (€380 million). As per the agreement, Roche will acquire complete rights ...

Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
By Nikita Chaurasia

Innovent Biologics Inc., in collaboration with American pharmaceutical giant Eli Lilly and Company, have reportedly announced that the biomarker results of ORIENT-11 trials which were displayed during a mini verbal presentation at ESMO (European Soci...